PPT-Dementia and Medication Considerations

Kelly Green Boesen PharmD BCPS CDE Overview of Medication Use Treatment of dementia Treatment of behavioral issues associated with dementia Medications to avoid Treatment of Dementia Cholinesterase inhibitors. Analysis of dementia prevalence rates by Delo itte Access Economics reveal coastal and regional NSW will continue to bear the brunt of increasing dementia prevalence rates while the metropolitan areas of the State will also experience a steady incre Presented by . Karla Brennscheidt, . psy.d. .. Owner, director. Clinical neuropsychologist – cedar valley . neurosycholoy. services, cedar falls. Outline . Aging Society . Iowa Data. Defining Dementia. Barry S. Fogel, MD. Brigham Behavioral Neurology Group. Harvard Medical School. Themes of This Presentation. Organizing Principles. Executive . Function and Metacognition. Why Assessors May Disagree . Colleen O’Connell, . PharmD. TMC Pharmacist. September 25, 2016. Objectives. Describe potential medication concerns with ostomies. List factors that influence medication availability and absorption with ostomies. Kingston Borough Neighbourhood watch. Speakers. Alison McWhinnie. Chair. Kingston Borough NHW Association. PC Paolo . Resteghini. Mental Health Liaison Officer. Kingston Police. Introduction. This presentation will cover the Kingston Borough NHW Dementia Project and other work that helps support this. Stephen Wey, . Katie . Egdell. , . Efterpi. . Theocharous. . Carly . Brewster, Joanne Tuffs, Kelly Williams, . April . Dennehy. The project. SCoRe. project (students as co-researchers). PhD . project. Jill Pendleton – Dementia Lead Liverpool. Ian . Mc. . Conville. - Riverside Life Enhancing Technologies Team Leader. Will Henderson – Clinical Research and Innovation Practitioner. Dementia can be defined as a set of symptoms that may include memory loss, difficulties with thinking, problem-solving and language problems. Associate Professor Michael Woodward AM. Port Lincoln . April 2017. Scope of talk. The progression of Alzheimer’s disease. New diagnostic approaches. Prevention. Treatment. Other research. Conclusions. Laura J. Fochtmann, MD, . MBI. Distinguished Service Professor, Departments of Psychiatry, Pharmacological Sciences and Biomedical Informatics, Stony Brook University. Medical Editor, Practice Guidelines. . Mary . Guerriero. Austrom, PhD. Wesley P Martin Professor of AD Education. Associate Dean for Diversity and Inclusion, IUSM. Director Outreach and Recruitment Core. Indiana Alzheimer Disease Center. Basics. Developed by:. University . of Wisconsin Oshkosh . Center for Community Development, Engagement and Training  (CCDET). Wisconsin . Department of Health Services . Division of Quality Assurance . the brain Factsheet 456LP April 2019 Knowing more about the brain and how it can change can help to understand the symptoms of dementia. It can help a person with dementia to live well, or to suppor Current Realities and Future Possibilities. Peter V. Rabins, MD, MPH. Johns Hopkins School of Medicine . Dementia Syndrome. Declines in 2 or more cognitive capacities. Normal level of consciousness and alertness. Dementia is a serious brain disease that affects memory, ability to make decisions, daily functioning, as well as mood and behavior. Vascular dementia is a type of dementia caused by a stroke. Alzheimer’s is the most common form of dementia and vascular dementia is the second most common for people age 65 and older. .